Related Experiment Video
Updated: May 5, 2026

5/6 Nephrectomy Using Sharp Bipolectomy Via Midline Laparotomy in Rats
Published on: April 4, 2025
Complement Dysregulation in Kidney Diseases: Mechanisms, Biomarkers, and Emerging Targeted Therapies
Patryk Jesiołowski1,2, Mateusz Krzywda1, Agnieszka Furmańczyk-Zawiska1
1Department of Transplantology, Immunology, Nephrology and Internal Medicine, Medical University of Warsaw, 02-091 Warsaw, Poland.
Insights
The complement system defends against pathogens but its dysregulation causes kidney disease. Targeting complement components offers new therapeutic strategies for various nephropathies.
Area of Science:
- Immunology
- Nephrology
- Molecular Biology
Background:
- The complement system is crucial for innate immunity, involving classical, lectin, and alternative pathways.
- Complement activation produces anaphylatoxins (C3a, C5a) and opsonins (C3b), influencing inflammation and pathogen clearance.
- Dysregulation of complement contributes to renal pathology, including acute kidney injury, lupus nephritis, IgA nephropathy, C3 glomerulopathy, and atypical hemolytic uremic syndrome.
Purpose of the Study:
- To review the dual role of the complement system in renal disease pathogenesis and therapeutic potential.
- To highlight complement components as predictive markers in acute kidney injury and specific nephropathies.
- To discuss genetic defects in complement regulation and their link to renal failure.
Main Methods:
- Review of scientific literature on complement system function in renal diseases.
- Analysis of complement component levels as predictive markers.
- Examination of genetic defects and therapeutic interventions targeting the complement system.
Main Results:
- Complement dysregulation, including overproduction of anaphylatoxins and membrane attack complex formation, drives renal disease.
- Complement component levels are valuable predictive markers, particularly in alternative pathway-driven conditions and immune complex diseases.
- Genetic defects in complement regulation lead to severe renal conditions like C3 glomerulopathy and atypical hemolytic uremic syndrome.
- Targeted therapies (eculizumab, pegcetacoplan) show promise in treating complement-mediated nephropathies.
Conclusions:
- The complement system plays a significant role in the initiation and progression of renal diseases.
- Understanding complement pathways is key to developing effective biomarkers and targeted therapies for nephropathies.
- Therapeutic strategies targeting complement components offer significant potential for improving patient outcomes in various kidney diseases.
Abstract:
The complement system is the primary defense mechanism against pathogens, acting through opsonization, the membrane attack complex, and classical, lectin, or alternative pathways. These pathways result in the production of key complement components, including C3a (complement component), C5a, and C3b, which recruit inflammatory cells. Complement dysregulation leads to renal disease through the overproduction of anaphylatoxins or inappropriate formation of the membrane attack complex. The levels of complement components have been shown to be useful as predictive markers in acute kidney injury, especially in conditions of alternative pathway activation, and in diseases of immune complex pathology such as lupus nephritis and IgA nephropathy. Genetic defects in complement regulatory proteins result in diseases such as C3 glomerulopathy or atypical hemolytic uremic syndrome, in which uncontrolled C3 convertase activity results in renal failure. Therapeutic interventions targeting complement components, including eculizumab or pegcetacoplan, improve patient outcomes in atypical hemolytic uremic syndrome and C3 glomerulopathy, respectively, while other interventions improve renal function in IgA nephropathy. These findings underscore the dual role of the complement system, which is not only implicated in the progression of renal diseases but also provides the potential for the development of therapeutic interventions for the treatment of various forms of nephropathy.
Related Concept Videos
Chronic Kidney Disease III: Interprofessional Care
Chronic Kidney Disease I: Introduction
Nephrotic Syndrome I : Introduction
Chronic Kidney Disease II: Clinical Manifestations
Chronic Kidney Disease IV: Nursing Management
Acute Kidney Injury II: Pathophysiology

